Publication

Quantifying effects of radiotherapy-induced microvascular injury; review of established and emerging brain MRI techniques

Kłos, J., van Laar, P. J., Sinnige, P. F., Enting, R. H., Kramer, M. C. A., van der Weide, H. L., van Buchem, M. A., Dierckx, R. A. J. O., Borra, R. J. H. & van der Hoorn, A., 5-Nov-2019, In : Radiotherapy and Oncology. 140, p. 41-53 13 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Copy link to clipboard

Documents

  • 64900833_4711379_Rewiew_peer-reviewed_for_the_library_l

    Final author's version, 335 KB, PDF-document

    Embargo ends: 05/06/2020

    Request copy

  • Quantifying effects of radiotherapy-induced microvascular injury; review of established and emerging brain MRI techniques

    Final publisher's version, 1 MB, PDF-document

    Request copy

DOI

Microvascular changes are increasingly recognised not only as primary drivers of radiotherapy treatment response in brain tumours, but also as an important contributor to short- and long-term (cognitive) side effects arising from irradiation of otherwise healthy brain tissue. As overall survival of patients with brain tumours is increasing, monitoring long-term sequels of radiotherapy-induced microvascular changes in the context of their potential predictive power for outcome, such as cognitive disability, has become increasingly relevant. Ideally, radiotherapy-induced significant microvascular changes in otherwise healthy brain tissue should be identified as early as possible to facilitate adaptive radiotherapy and to proactively start treatment to minimise the influence on these side-effects on the final outcome.

Although MRI is already known to be able to detect significant long-term radiotherapy induced microvascular effects, more recently advanced MR imaging biomarkers reflecting microvascular integrity and function have been reported and might provide a more accurate and earlier detection of microvascular changes. However, the use and validation of both established and new techniques in the context of monitoring early and late radiotherapy-induced microvascular changes in both target-tissue and healthy tissue currently are minimal at best.

This review aims to summarise the performance and limitations of existing methods and future opportunities for detection and quantification of radiotherapy-induced microvascular changes, as well as the relation of these findings with key clinical parameters. (C) 2019 Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)41-53
Number of pages13
JournalRadiotherapy and Oncology
Volume140
Publication statusPublished - 5-Nov-2019

    Keywords

  • Radiotherapy-induced injury, Susceptibility-weighted imaging (SWI), Quantitative susceptibility mapping (QSM), Dynamic susceptibility contrast MRI (DSC-MRI), Cerebral microbleeds (CMB), Microvascular, SMALL VESSEL DISEASE, WHITE-MATTER LESIONS, CENTRAL-NERVOUS-SYSTEM, CEREBRAL CAVERNOUS MALFORMATIONS, RADIATION-INDUCED CHANGES, LONG-TERM SURVIVORS, LOW-GRADE GLIOMAS, CAPILLARY TELANGIECTASIA, CRANIAL IRRADIATION, BLOOD-VOLUME

View graph of relations

ID: 84872700